Evaluation of VELCADE (Botezomib) for Injection Employed as Re-Treatment for Efficacy, Safety, and Tolerability
Phase of Trial: Phase IV
Latest Information Update: 08 Feb 2008
At a glance
- Drugs Bortezomib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms EVEREST
- 08 Feb 2008 Status changed from in progress to completed according to ClinicalTrials.gov.
- 12 Jul 2007 Status changed from recruiting to in progress.
- 24 Nov 2005 New trial record.